Miahelsa Holdings Corporation Q3 FY2025 earnings call

• Overall Consolidated Performance

  • The third quarter delivered 4.8% year-over-year revenue growth and 49% year-over-year operating profit growth, achieving both top and bottom line growth compared to the prior year period.
  • All three operating segments achieved year-over-year revenue and profit growth. All core financial metrics beat management's original quarterly forecast: revenue exceeded forecast by 630.43 million yen, operating income exceeded forecast by 113.53 million yen, ordinary income exceeded forecast by 111.85 million yen, and quarterly net income exceeded forecast by 26.97 million yen.
  • Net quarterly income included both special gains (facility opening subsidies for the Hazawa Nursery School in Yokohama and construction delay guarantee deposits) and special losses (impairment losses on underperforming facilities in the pharmaceutical and childcare support segments).

• Profitability Improvement Initiatives

  • Management closed 1 unprofitable Tokyo certified nursery school at the end of March 2024 and 4 unprofitable day care nursing locations during the March 2024 fiscal year, which delivered material improvements to segment profitability in the current quarter.
  • High stable occupancy of service-based senior housing supported stable utilization of attached care facilities, improving overall segment stability.

• Organic Growth Drivers

  • Pharmaceutical revenue growth was driven by higher prescription volume from new store openings. Childcare revenue growth came from rising enrollment at 3 approved nursery schools and 1 after-school club opened in April 2023, plus the approved public price increase. Nursing care growth was driven by rising utilization at the new 61-bed hospice-capable care home in Nagareyama.

1. Pharmaceutical Business: Revenue grew 3.3% year-over-year, segment profit grew 1.9% year-over-year. Total prescription volume increased 6.3% year-over-year, driven by new store openings; new stores added 15,000 more prescriptions than the prior year period, leading to a net total increase of 14,000 prescriptions. Average prescription price decreased 740 yen year-over-year due to new store locations in low average prescription price clinic prescription areas and drug price revisions.
2. Childcare Support Business: Revenue grew 5.1% year-over-year, segment profit grew 14.1% year-over-year. Total childcare center enrollment saw a net decrease of 27 children year-over-year, with 96 children added from new approved centers offset by 123 children lost from the closed non-profitable center and declining enrollment at existing centers. The number of total childcare centers remained unchanged. Revenue grew due to an approved public price increase from the Japanese Agency for Children and Families, and profit grew from improved profitability of new centers and efficiency gains after closing the unprofitable center.
3. Nursing Care Business: Revenue grew 8.5% year-over-year. Segment profit reached 10 million yen, turning to a net profit from a year-over-year prior loss of 81.6 million yen, representing a more than 91 million yen year-over-year improvement. Compared to the prior year third quarter, day service users increased by 222 people, occupancy rose 0.1 percentage points, and service-based senior housing occupancy improved 1.6 percentage points year-over-year. Profit turned positive after closing 4 unprofitable day service locations, and grew from rising occupancy at the new hospice-capable care home opened in Nagareyama and stable high occupancy of service-based senior housing.

• Full year 2025 March fiscal year guidance remains unchanged from the original disclosure released in May of the prior year.
• Progress against the full year forecast is on track as of the third quarter: 77.3% of full year revenue, 84.4% of full year operating profit, 84.8% of full year ordinary profit, and 73.1% of full year net profit have been achieved through the first three quarters.
• Management outlined targeted operational priorities for the fourth quarter:
  • Pharmaceutical business: Strengthen generic drug dispensing system add-on revenue alongside securing technical fee add-ons
  • Childcare support business: Continue growing enrollment at existing childcare centers, and strengthen recruitment efforts for nursery teachers
  • Nursing care business: Maintain high occupancy of service-based senior housing via continued targeted sales efforts, grow utilization of attached care services, increase occupancy at the hospice-capable care home, and secure and retain nursing staff to support stable operations

No explicit risk discussion was included in the published transcript portion. The only potential operational challenges referenced are lower average prescription prices driven by new store location mix, and enrollment declines at some existing childcare centers, both of which have been partially offset by other growth and profitability initiatives.

No question and answer section was included in the published transcript portion provided.